# Progress Note 07 — Focused Visit (Care-plan review)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sitting Bull (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI015-SYN
- Date: 2026-10-26
- Fictional facility: St. Posthumous Health Center
- Fictional author: Wenona Talltree-Hastings, MD
- Calendar frame: modern shifted

- Visit type: Focused Visit (Care-plan review)

## Chief complaint

Sixteen-week review: foot, prediabetes, food and his plan for the year. **S**

## History of present illness

Sitting Bull returns five weeks after his preventive visit, with the interpreter. His pain on walking has crept up to 4 of 10 as the injection wears off, eleven weeks after it was given; he still walks and rides with the brace. He has eaten less flour, lard and sugar and more bison and vegetables from the food distribution program and his garden, and he has joined the walking group run by the diabetes prevention program as far as his foot allows. His stool test and the HIV and hepatitis C tests were negative; the hepatitis B test showed he is not immune. He says his own ways of healing are part of how he is doing; he did not describe them, and the clinic did not ask. He would like his Tdap and hepatitis B vaccines today. **S**

| Element | Detail |
|---|---|
| Pain | 4 of 10 on walking |
| Function | Foot and Ankle Ability Measure, daily activities, 76% |
| Hemoglobin A1c | 5.8%, from 6.0% |
| Screening results | Stool test, HIV and hepatitis C negative; not immune to hepatitis B |
| Food | Food distribution program and a larger garden |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Musculoskeletal | Positive | Left hindfoot pain returning slowly |
| Gastrointestinal | Negative | No stomach pain off omeprazole |
| Psychiatric | Negative | Mood steady; sleeping well |

3 systems reviewed. **S**

## Current medications

- Diclofenac sodium 1% topical gel, 4 g rubbed into the left ankle and hindfoot four times daily, using the dosing card **S**
- Acetaminophen 500 mg oral tablet, one or two tablets every 6 hours as needed for foot pain, no more than 3,000 mg a day **S**

## Allergies

- No known allergy **S**

## Objective

BP 122/76 mmHg; pulse 68 bpm; respirations 16/min; temperature 36.6 °C; oxygen saturation 98% on room air; weight 80 kg; BMI 25.2 kg/m². All vital signs are synthetic.

Pain (0-10): 4; Hemoglobin A1c: 5.8% (high); PHQ-9: 3. All results are synthetic.

## Change since baseline

- Pain (0-10): 7 at baseline, 4 at this visit **S**
- Hemoglobin A1c: 6% (high) at baseline, 5.8% (high) at this visit **S**
- PHQ-9: 6 at baseline, 3 at this visit **S**

## Immunizations given today

- Tdap vaccine, deferred from the preventive visit at his request **S**
- Hepatitis B vaccine (HepB-CpG), first of two doses; screening showed he is not immune **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; blood pressure 122/76, pulse 68; weight 80.0 kg, BMI 25.2 |
| Left foot and ankle | Subtalar motion painful at the end of range; no swelling; skin intact under the brace |
| Gait | Mild limp in the brace |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Post-traumatic osteoarthritis of the left hindfoot** (M19.172). Pain 4 of 10 as the injection wears off; function still much better than at intake. A second injection can be given after three months from the first, in two weeks or later, if he wishes; surgery remains his choice to raise. **S**
   - A second ultrasound-guided subtalar injection booked in three weeks at his request.
   - Continue the brace, home exercises, diclofenac gel and acetaminophen as needed.
2. **Prediabetes** (R73.03). Hemoglobin A1c 5.8%, from 6.0%, with weight down 2 kg. **S**
   - Continue the prevention program; hemoglobin A1c yearly.
3. **Food insecurity** (Z59.41). Enough food through the month with the food distribution program and the garden. **S**
   - The Community Health Representative will check in before winter.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Pain on walking (0 to 10 numeric rating scale) | Every visit and after each treatment trial | Completed today | 4 of 10, eleven weeks after the injection |
| Survey | Function: Foot and Ankle Ability Measure, activities of daily living subscale | Every visit | Completed today | 76%, from 81% at ten weeks and 52% at baseline |
| Examination | Joint examination: hindfoot and ankle motion, alignment, swelling and gait | Every visit | Completed today | Painful end-range subtalar motion; no swelling |
| Self-management | Exercise, physical therapy and brace use | Every visit; physical therapy weekly for six weeks | Completed today | Home exercises and the walking group |
| Medication safety | NSAID safety: blood pressure, creatinine and blood count; stomach symptoms | Before an oral NSAID, then every 6 to 12 months on long-term use | Not indicated | No oral NSAID since the sick visit |
| Imaging | Imaging | At diagnosis or for surgical planning; not for routine follow-up | Not indicated | No new symptoms; no surgery planned |
| Laboratory | Blood lead with retained bullet fragments | Once when fragments are found; repeat only if fragments lie in a joint or bone, or symptoms suggest lead toxicity | Not indicated | No symptoms of lead toxicity; fragments outside the joints |
| Examination | Blood pressure, with home readings to confirm or exclude hypertension | Every visit | Completed today | 122/76 mmHg |
| Survey | Depression screening, sleep and coping | At baseline and periodically | Completed today | PHQ-9 3, item 9 scored 0 |
| Laboratory | Hemoglobin A1c in prediabetes | At diagnosis, then in three to four months and yearly | Completed today | 5.8%, from 6.0% |
| Self-management | Food access and the food distribution program | Every visit | Completed today | Food distribution program and a larger garden; enough food through the month |
| Self-management | Traditional healing alongside clinic care, at his choice | Every visit | Completed today | His own ways of healing continue, as he chooses; nothing asked |

## Goal progress

- Walk a mile on uneven ground and ride with pain of 3 or less. Outcome by 2026-09-14: Pain 7 to 3 of 10 on walking; walking more than a mile with the brace; riding again. **S**
- Decide about surgery with full information, in his own time. Outcome by 2026-09-14: Arthrodesis explained with its risks and recovery; he chose to wait and will raise it again if needed. **S**
- Bring hemoglobin A1c below 5.7%. Outcome by 2026-10-26: 6.0 to 5.8%, with more walking, less flour, lard and sugar, and more garden vegetables and bison. **S**
- Enough food through the month. Outcome by 2026-10-26: Enrolled in the Food Distribution Program on Indian Reservations, including bison and other traditional foods, and a larger garden. **S**

## Guideline basis

- 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019), American College of Rheumatology and Arthritis Foundation (Arthritis Care & Research 2020;72(2):149-162)
- CMID: Clinical Monitoring Intelligence Database, rheumatoid arthritis and osteoarthritis and depression, bipolar, and mood disorders monographs (2026), Aether Forge
- Indian Health Manual, Part 3, Chapter 30: Chronic Non-Cancer Pain Management (2026), Indian Health Service
- Special General Memorandum 94-08: Statement of Policy for the Traditional Cultural Advocacy Program (1994), Indian Health Service
- Special Diabetes Program for Indians (2026), Indian Health Service
- Food Distribution Program on Indian Reservations (2026), U.S. Department of Agriculture, Food and Nutrition Service
- Prediabetes and Type 2 Diabetes: Screening (2021), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Tdap and the first hepatitis B dose given today; second hepatitis B dose in one month or more; second zoster dose in two to six months after the first. Subtalar injection in three weeks. Review in three months. **S**

